Articles from The Motley Fool

Choosing one over the other boils down to one very personal detail. But the detail's different for every person.

Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4.

Trump is set to inherit one of the priciest stock markets in over 150 years.

Nobody doubts its resiliency. But resiliency doesn't always mean sustained explosive growth is in the cards.

Lowering your yearly tax bill can be just as good as getting a raise.

This strategy is practically off limits for the pros, but it does a better job than most.

Big changes may be on the way for America's leading retirement program if Congress fails to act.

A handful of bullish factors are converging at the right time in the right way for all three of these companies.

A promising technology does not necessarily guarantee a stock will do well.

The path to financial independence is a journey, not a destination. There are lessons to learn along the way.

Consider these pros and cons before starting a position in this leading cryptocurrency.

The legendary investor is loading up on cash for Berkshire Hathaway's balance sheet.

The nuclear power start-up craze has investors looking past two very likely winners from nuclear and the global energy transition.

Think all the best tech stocks are overpriced today? These two hidden gems are hiding in plain sight at the intersection of Wall Street and Silicon Valley.

The number is probably bigger than you think, but it's still far from enough to cover a retiree's expenses.

Missed your chance to invest in Astra Space? Have no fear. There's still time to invest in Rocket Lab, Airbus, Boeing, Lockheed Martin, and Northrop Grumman.

The software-as-a-service sector is an attractive area to search for promising growth stocks.

I declared defense stocks overpriced three months ago. Today, I'm doubling down on that winning bet.

This loophole could be the thing that saves your retirement.